[ad_1]
“If the existing plan for vaccination of the population in Greece is implemented within the first half of 2021, we will theoretically have full immunity in the summer,” EOF President Dimitris Filippou said on SKAI TV.
As he explained, from the moment the first is vaccinated, it will take a month to acquire immunity. So if the existing population vaccination plan is implemented within the first half of the year, we will theoretically have full immunity in the summer. So many months go by.
Regarding the approval process of the vaccine, the president of the EOF stated that the approval is a central process by the EMA, then it reaches the national organizations of each country, which determines the form of distribution, that is, to where will go and in what way it will be distributed and the conditions are determined. particular restrictions imposed by each country.
Among other things, he stressed that EOF is ready. “It is a process that has been going on for a long time. It is not happening now and we are in constant communication with the European Medicines Agency. We already know that from the end of December the decision for approval by the EMA will be made, so within 24 hours the mechanisms will be those who should be – even if it is the New Year – to quickly make the decision on the mode of disposal.
Regarding when the decision will be made and made available in Greece, Mr Filippou stressed that, based on the information available from the European Medicines Agency, the decision is considered to be made on December 3, 10 days: the marketing approval of the vaccine. it will be Pfizer’s first and there will be more. “Once this is done, it will take a couple of days for the procedure to be carried out, and he added at the national level, and then begin its distribution with the perspective of starting vaccination in the first 15 days of January.”
The president of the EOF stressed that in this vaccination process the EOF is not alone and that it is a giant company that requires the cooperation of many and that is based on specific specifications that must be followed at each stage of the process so that everything is correct and without problems. .
Regarding whether the vaccine is safe, he said that approval is not a simple process and that is why the EMA has been delayed. “EMA is a meticulous safety organization.” The main thing is that the vaccine is safe and that the EMA will make sure of that. ”
Regarding the approval given earlier in Britain, he said that each drug organization follows its own criteria and that the Greek organization follows European criteria that have not been refuted so far.
About the drug “Trump’s famous antibody cocktail noted that it is a drug that has received special approval from the United States, it is not a marketing authorization.” He has an emergency license. There is no such approach either at national or European level.
However, as he underlined, “at least from Regeneron we made sure to secure the doses in a clinical trial. In case the companies submit an application for EMA approval and it is approved, it will obviously also reach Greece.”
The study for this drug has been approved as mentioned and will take place within a week in Greece and will start in 5 hospitals.
Source: skai.gr
